Norcliffe Capital
Europe, East Sussex, United Kingdom, Wadhurst'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Norcliffe Capital provides tax-efficient investments in the life science and disruptive technology sectors.
Investor Profile
Norcliffe Capital has backed more than 9 startups, with 2 new investments in the last 12 months alone. The firm has led 3 rounds, about 33% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Biotechnology, Medical, Health Care.
Stage Focus
- Seed (56%)
- Series A (22%)
- Series Unknown (22%)
Country Focus
- United Kingdom (89%)
- United States (11%)
Industry Focus
- Biotechnology
- Medical
- Health Care
- Health Diagnostics
- Machine Learning
- Biopharma
- Manufacturing
- Hospital
- Medical Device
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
